The purpose of this American Heart Association-funded and NIH-funded study is to examine circulating RNAs in the acute congestive heart failure (CHF) setting, and how they change with decongestive therapy, and their function in vitro and in vivo. The investigators are testing the hypothesis that ex-RNA levels change significantly during decongestion therapy and can be used as a marker of those individuals who respond to CHF therapy (in terms of cardiac structure or outcome). Additionally, the translational research design allows the investigators to assay the effects of these RNAs on tissue phenotypes in vitro.

Circulating RNAs in Acute Heart Failure (CRUCIAL)

Heart Failure study with RNA-Seq data on dbGaP (41 participants)

Circulating RNAs in Acute Heart Failure (CRUCIAL)

Description

Applying For Access

Summary